DailyIQ
|
Sector:HealthcareAll sectors
Last updated 4 minutes ago

MOH·Molina Healthcare, Inc.

$.
+. (+.%)
After Hours
High
$235.99
Open
$233.41
Market Cap
12.16B
52W High
$243.50
Low
$229.28
P. Close
$233.36
P/E
64.66
52W Low
$121.06
Fwd P/E
25.41
DailyIQ Est.
$192.00
Technical Score (1D)
91
BUY
News Sentiment
70
BULLISH
RBC Capital has lifted Molina Healthcare’s price target to $248 from $216, citing a stronger growth outlook that hinges on Medicare Advantage expansion and fee‑for‑service revenue, which implies a potential upside in the next 1–10 trading days. However, Barclays has cut its target to $184, arguing that valuation concerns outweigh the growth narrative, creating uncertainty about the stock’s fair value range. The conflicting analyst views mean traders should watch the upcoming earnings release for clarity on revenue growth and margin performance. Argus Research also raised its target to $245, reinforcing the bullish consensus around the company’s earnings trajectory. A broader index shift toward value stocks could lift demand for MOH shares, suggesting a possible momentum boost if investors reallocate from growth to income‑generating assets. CMS’s final 2025 risk‑adjustment figures added a modest $11.2 million in payments, a slight negative hit that may dampen short‑term earnings but is unlikely to derail the growth narrative. RBC’s recent note that Medicaid reimbursement uncertainties have not yet materially impacted the outlook further supports a stable near‑term path. Traders should watch the upcoming earnings report, any updates to Medicaid rate negotiations, and the pace of Medicare Advantage contract renewals to gauge whether the bullish or bearish narrative prevails.
Earnings Summary
Molina Healthcare is a managed care provider that delivers health plans through Medicaid and Medicare programs, focusing on low‑income populations across the United States; it operates through Medicaid, Medicare, Marketplace, and Other segments and has been a stable presence in the healthcare plans sector since 1980. In the most recent quarters, the company’s revenue grew from $10.50 billion in Q4 2024 to $11.15 billion in Q1 2025 (+6.3%) and then to $11.43 billion in Q2 2025 (+2.5%), before plateauing at $11.48 billion in Q3 2025 and slightly declining to $11.38 billion in Q1 2026; EPS, however, has been volatile, with a miss in Q4 2024 (5.05 vs 5.88), a beat in Q1 2025 (6.08 vs 5.96), misses in Q2 2025 (5.48 vs 5.53), Q3 2025 (1.84 vs 3.89), Q4 2025 (‑2.75 vs 0.34), and a beat again in Q1 2026 (2.35 vs 1.94). Historically, the company has posted two EPS beats out of six quarters, with revenue growth slowing in the most recent period and EPS largely missing estimates; the pattern suggests modest top‑line expansion but earnings volatility. Recent news highlights RBC’s upgrade of the price target to $248, driven by expectations of stronger revenue and margin expansion, while an index realignment has positioned Molina as a value play, potentially increasing demand; the CMS risk‑adjustment release added $11.2 million in payments, a modest negative impact that could influence future earnings forecasts. Investors should watch the Q2 2026 earnings release for confirmation of revenue versus estimates, potential margin changes, and any regulatory updates that could affect Medicare reimbursement or Medicaid rate negotiations, as these factors will be key to assessing the company’s near‑term trajectory.

EPS

EstBeatMiss
$-4.07$-1.20$1.67$4.53$7.40Q1'25Q2'25Q3'25Q4'25Q1'26Q2'26
QtrEstActual+/−
Q2'26$1.40 - -
Q1'26$1.94$2.35+21.4%
Q4'25$0.34$-2.75-916.0%
Q3'25$3.89$1.84-52.7%
Q2'25$5.53$5.48-0.9%
Q1'25$5.96$6.08+2.1%

Revenue

EstBeatMiss
$10.7B$10.9B$11.1B$11.4B$11.6BQ1'25Q2'25Q3'25Q4'25Q1'26Q2'26
QtrEstActual+/−
Q2'26$10.9B - -
Q1'26$10.9B$10.8B-0.8%
Q4'25$11.0B$11.4B+3.7%
Q3'25 - $11.5B -
Q2'25 - $11.4B -
Q1'25 - $11.1B -
Full Earnings BreakdownEstimates, actuals, guidance, and historical context
→

Market Data

MOH Stock Snapshot

MOH is currently trading at $233.31, giving Molina Healthcare, Inc. a market cap of 12.16B and a P/E ratio of 64.7. Today's range spans $229.28–$235.99, with shares opening at $233.41 and moving down $0.05 (0.0%) from the prior close. DailyIQ's technical score sits at 91/100 (BUY) with a news sentiment reading of 70/100.

Over the past year MOH has traded between $121.06 and $243.50 - the current price is +92.7% off the 52-week low and -4.2% from the high. 26 analysts cover the stock with a Hold consensus and a mean 12-month target of $192.76 (range $129.00–$262.00), implying downside of -17.4%.

Growth-oriented Healthcare investors looking for technical confirmation find it in MOH: BUY signal, 91/100 score, bullish sentiment at 70/100, price $233.31 (near 52-week highs). The current P/E ratio stands at 64.7. The 12.16B market cap is the sweet spot - big enough to absorb institutional sizing, small enough to move materially on conviction. Annual range: $121.06–$243.50.

Earnings revision cycles in large-cap Healthcare names tend to compound: when technicals confirm a BUY thesis (91/100) and news sentiment (70/100, bullish) supports the narrative, analyst upgrades follow price rather than lead it. At $233.31 (near 52-week highs), MOH's position within the $121.06–$243.50 annual range suggests there's room for multiple expansion before the stock encounters meaningful technical resistance.